Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Breast Neoplasms 5Prostatic Neoplasms 4Multiple Myeloma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Mycosis Fungoides 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Hairy Cell 3Leukemia 3Hodgkin Disease 3Head and Neck Neoplasms 3Brain Neoplasms 3Blast Crisis 3Melanoma 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

Palonosetron 13Aprepitant 13Dexamethasone 11Ondansetron 10fosaprepitant 4Olanzapine 4Granisetron 3Calcium Dobesilate 3ramosetron 2netupitant 2Tropisetron 2Radiotherapy 2Fluorouracil 2rolapitant 1netupitant, palosentron drug combination 1ginger extract 1dolasetron 1casopitant 1Yoga 1Therapeutics 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Pantoprazole 1Paclitaxel 1Oxaliplatin 1Octreotide 1Megestrol Acetate 1Megestrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Vomiting × Therapeutics × Clear all
NCT01534637 2018-08-15

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Wake Forest University Health Sciences

Phase 2 Completed
22 enrolled 9 charts
Gastrointestinal

Bile Duct Neoplasms, Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡